Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS).

HOME
>
論文・技術情報
>
Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS).

アブストラクト
ジャーナル名	JAAD international
投稿日	2022/10/18
投稿者	Yeroushalmi, Samuel; Chung, Mimi; Bartholomew, Erin; Hakimi, Marwa; Koo, John
組織名	Department of Dermatology, University of California, San Francisco, San;Francisco, California.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/36248199/

タグ:

お問合わせ

キーワード